Neutrophil to lymphocyte ratio, PD-L1 expression, and survival in patients with advanced non-small cell lung cancer receiving first-line immune checkpoint inhibitor therapy.
ASCO, February 10, 2020
Intra-tumoral microbes correlate with tumor-infiltrating lymphocytes in lung cancer biopsies
American Association for Cancer Research: Microbes & Viruses, Feb 23, 2020, Orlando, FL; Presenter: Dan Spakowicz
Poster Abstract Table of correlations between microbes and immune cells for each cancer
Abstract B30: Intratumoral microbes correlate with tumor-infiltrating lymphocytes in lung cancer RNAseq
AACR, April 2020
Neutrophil-lymphocyte score: A novel prognostic scoring system that utilized the dynamic change of neutrophil, lymphocyte, and albumin and its comparison to other indices
ASCO Journal of Clinical Oncology, May 20, 2020
Inhaled corticosteroid use and risk of pneumonitis in patients treated with immune checkpoint inhibitors.
ASCO, Journal of Clinical Oncology, May 20, 2020
Platelets impact the responsiveness of immune checkpoint blockade therapy in solid tumors.
ASCO Journal of Clinical Oncology, May 25, 2020
Changes in lymphocyte/monocyte ratio, prognostic marker to predict overall survival in patients with advanced cancer treated with immune checkpoint inhibitor
ASCO, Journal of Clinical Oncology, May 20, 2020
Intra-tumoral mirobes and overall survival in colorectal cancer patients.
ASCO, 2020
Re-evaluating the neutrophil-to-lymphocyte ratio: Machine learning-based variable selection for predicting survival at twelve months in late-stage cancer patients receiving immunotherapy
ASCO Journal of Clinical Oncology, May 26, 2019
Is immunotherapy toxicity associated with improved overall survival among older adults with advanced cancer?
ASCO, June 2019